sb 203580 has been researched along with 2',4',6'-tris(methoxymethoxy) chalcone in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (2',4',6'-tris(methoxymethoxy) chalcone) | Trials (2',4',6'-tris(methoxymethoxy) chalcone) | Recent Studies (post-2010) (2',4',6'-tris(methoxymethoxy) chalcone) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 10 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jin, XY; Kim, HD; Kim, JY; Lee, SH; Seo, GS; Sohn, DH | 1 |
1 other study(ies) available for sb 203580 and 2',4',6'-tris(methoxymethoxy) chalcone
Article | Year |
---|---|
Heme oxygenase 1 mediates anti-inflammatory effects of 2',4',6'-tris(methoxymethoxy) chalcone.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Blotting, Northern; Blotting, Western; Cell Line; Chalcones; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression; Glutathione; Heme Oxygenase-1; Imidazoles; Intracellular Fluid; Lipopolysaccharides; Macrophage Activation; Macrophages; Mitogen-Activated Protein Kinases; Molecular Structure; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Pyridines; Reactive Oxygen Species; RNA, Messenger | 2006 |